Champions Oncology Company

Champions Oncology was founded by some of the world’s most renowned specialists in the field of cancer diagnosis, treatment, and research. Our team is comprised of seasoned oncology professionals passionately dedicated to working with you to accelerate oncology drug development, improve outcomes and extend lives. Our core platform, the Champions TumorGraft™ offers an enhanced xenograft mouse avatar model for growing and testing human tumors.
Technology: Cancer
Industry: End-to-end Drug Development
Headquarters: Hackensack, New Jersey, United States
Founded Date: 1985-01-01
Employees Number: 51-100
Funding Status: IPO
Investors Number: 4
Total Funding: 36800000
Estimated Revenue: $1M to $10M
Last Funding Date: 2015-03-12
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership